Sigma Planning Corp
STRO icon

Sigma Planning Corp’s Sutro Biopharma STRO Stock Holding History

Sigma Planning Corp’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-45,020
Closed -$1.49M – 1439
2026
Q2 		$1.49M Buy
45,020
+32,500
+260% +$1.01M 0.04% 456
2026
Q1 		$312K Buy
+12,520
New +$226K 0.01% 1037

Other funds holding STRO

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Achmea Investment Management
Achmea Investment Management Zeist, Netherlands $12.6B AUM 25.68% 1-Year Est. Return
State of Wyoming
State of Wyoming Cheyenne, Wyoming $1.29B AUM 32.25% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

Sigma Planning Corp's STRO Position: Q3 2026 in Review

Sigma Planning Corp sold out of Sutro Biopharma (STRO) in Q3 2026, closing a stake of 45,020 shares — an estimated $1.49M sold.

Sigma Planning Corp first reported a position in STRO in Q1 2026 and held it in 2 quarters. The position peaked at $1.49M in Q2 2026. 21 funds tracked by Wall St. Rank hold STRO as of Q3 2026.

  • Sigma Planning Corp reported no remaining Sutro Biopharma position as of Q3 2026 after selling out during the quarter.
  • Sigma Planning Corp sold 45,020 Sutro Biopharma shares in Q3 2026, an estimated $1.49M.
  • Sigma Planning Corp first reported a position in Sutro Biopharma in Q1 2026 and held it in 2 quarters.
  • Sigma Planning Corp's Sutro Biopharma position peaked at $1.49M in Q2 2026.
  • 21 funds tracked by Wall St. Rank held Sutro Biopharma as of Q3 2026.

Based on Sigma Planning Corp's 13F filing for Q3 2026, filed 23 Oct 2026.